Literature DB >> 21406335

miRNA expression profiling of mycosis fungoides.

Marloes S van Kester1, Erica Ballabio, Marchina F Benner, Xiao H Chen, Nigel J Saunders, Leslie van der Fits, Remco van Doorn, Maarten H Vermeer, Rein Willemze, Cornelis P Tensen, Charles H Lawrie.   

Abstract

MicroRNAs (miRNAs) are small RNA species that regulate gene expression post-transcriptionally and are aberrantly expressed in many malignancies including lymphoma. However, the role of miRNAs in the pathogenesis of T-cell lymphoid malignancies is poorly understood. Previously we examined the miRNA profile of Sézary syndrome (Sz), a leukemia of skin-homing memory T cells. In this study we determined the complete miRNome of mycosis fungoides (MF), the most common type of cutaneous T cell lymphoma. The miRNA profile of skin biopsies from 19 patients with tumor stage MF and 12 patients with benign inflammatory dermatoses (eczema and lichen planus) were compared by microarray analysis. We identified 49 miRNAs that are differentially expressed in tumor stage MF compared to benign inflammatory dermatoses using ANOVA analysis (P < 0.05, Benjamini-Hochberg corrected). The majority of the differentially expressed miRNAs (30/49) were up-regulated in tumor stage MF. The most significant differentially expressed were miR-155 and miR-92a (both up-regulated in tumor stage MF), while miR-93 showed the highest up-regulation in tumor stage MF with a fold difference of 5.8. Differential expression of a selection of these miRNAs was validated by miRNA-Q-PCR on additional test groups (tumors and controls). None of the miRNAs up-regulated in tumor stage MF was previously shown to be up-regulated in Sz, and only 2 of the 19 miRNAs down-regulated in tumor stage MF were also down-regulated in Sz. Taken together this report is the first describing the miRNA signature of tumor stage MF.
Copyright © 2011 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21406335      PMCID: PMC5528293          DOI: 10.1016/j.molonc.2011.02.003

Source DB:  PubMed          Journal:  Mol Oncol        ISSN: 1574-7891            Impact factor:   6.603


  31 in total

1.  Normalization of cDNA microarray data.

Authors:  Gordon K Smyth; Terry Speed
Journal:  Methods       Date:  2003-12       Impact factor: 3.608

2.  MicroRNA miR-93 promotes tumor growth and angiogenesis by targeting integrin-β8.

Authors:  L Fang; Z Deng; T Shatseva; J Yang; C Peng; W W Du; A J Yee; L C Ang; C He; S W Shan; B B Yang
Journal:  Oncogene       Date:  2010-10-18       Impact factor: 9.867

3.  Sézary syndrome is a unique cutaneous T-cell lymphoma as identified by an expanded gene signature including diagnostic marker molecules CDO1 and DNM3.

Authors:  N Booken; A Gratchev; J Utikal; C Weiss; X Yu; M Qadoumi; M Schmuth; N Sepp; D Nashan; K Rass; T Tüting; C Assaf; E Dippel; R Stadler; C-D Klemke; S Goerdt
Journal:  Leukemia       Date:  2007-11-22       Impact factor: 11.528

Review 4.  Physiological and pathological roles for microRNAs in the immune system.

Authors:  Ryan M O'Connell; Dinesh S Rao; Aadel A Chaudhuri; David Baltimore
Journal:  Nat Rev Immunol       Date:  2010-02       Impact factor: 53.106

5.  The microRNA-17-92 cluster: still a miRacle?

Authors:  Angelika Bonauer; Stefanie Dimmeler
Journal:  Cell Cycle       Date:  2009-12-04       Impact factor: 4.534

Review 6.  MicroRNA signatures in human cancers.

Authors:  George A Calin; Carlo M Croce
Journal:  Nat Rev Cancer       Date:  2006-11       Impact factor: 60.716

7.  Expression of proliferation markers and cell cycle regulators in T cell lymphoproliferative skin disorders.

Authors:  Thilo Gambichler; Stefan Bischoff; Falk G Bechara; Peter Altmeyer; Alexander Kreuter
Journal:  J Dermatol Sci       Date:  2007-09-10       Impact factor: 4.563

8.  Aberrant expression of the tyrosine kinase receptor EphA4 and the transcription factor twist in Sézary syndrome identified by gene expression analysis.

Authors:  Remco van Doorn; Remco Dijkman; Maarten H Vermeer; Jacoba J Out-Luiting; Elisabeth M H van der Raaij-Helmer; Rein Willemze; Cornelis P Tensen
Journal:  Cancer Res       Date:  2004-08-15       Impact factor: 12.701

9.  Oligonucleotide array-CGH identifies genomic subgroups and prognostic markers for tumor stage mycosis fungoides.

Authors:  Rocío Salgado; Octavio Servitje; Fernando Gallardo; Maarten H Vermeer; Pablo L Ortiz-Romero; Maria B Karpova; Marie C Zipser; Cristina Muniesa; María P García-Muret; Teresa Estrach; Marta Salido; Júlia Sánchez-Schmidt; Marta Herrera; Vicenç Romagosa; Javier Suela; Bibiana I Ferreira; Juan C Cigudosa; Carlos Barranco; Sergio Serrano; Reinhard Dummer; Cornelis P Tensen; Francesc Solé; Ramon M Pujol; Blanca Espinet
Journal:  J Invest Dermatol       Date:  2009-09-17       Impact factor: 8.551

10.  miR-93, miR-98, and miR-197 regulate expression of tumor suppressor gene FUS1.

Authors:  Liqin Du; Jeoffrey J Schageman; Maria C Subauste; Barbara Saber; Scott M Hammond; Ludmila Prudkin; Ignacio I Wistuba; Lin Ji; Jack A Roth; John D Minna; Alexander Pertsemlidis
Journal:  Mol Cancer Res       Date:  2009-08-11       Impact factor: 5.852

View more
  36 in total

Review 1.  Role of microRNAs in lymphoid biology and disease.

Authors:  Muller Fabbri; Carlo M Croce
Journal:  Curr Opin Hematol       Date:  2011-07       Impact factor: 3.284

2.  Small noncoding RNAs in cells transformed by human T-cell leukemia virus type 1: a role for a tRNA fragment as a primer for reverse transcriptase.

Authors:  Katia Ruggero; Alessandro Guffanti; Alberto Corradin; Varun Kumar Sharma; Gianluca De Bellis; Giorgio Corti; Angela Grassi; Paola Zanovello; Vincenzo Bronte; Vincenzo Ciminale; Donna M D'Agostino
Journal:  J Virol       Date:  2014-01-08       Impact factor: 5.103

Review 3.  Evolving insights in the pathogenesis and therapy of cutaneous T-cell lymphoma (mycosis fungoides and Sezary syndrome).

Authors:  Henry K Wong; Anjali Mishra; Timothy Hake; Pierluigi Porcu
Journal:  Br J Haematol       Date:  2011-08-25       Impact factor: 6.998

Review 4.  Dysregulation of microRNAs and their association in the pathogenesis of T-cell lymphoma/leukemias.

Authors:  Sho Ikeda; Hiroyuki Tagawa
Journal:  Int J Hematol       Date:  2014-02-25       Impact factor: 2.490

5.  Downregulated expression of Dicer1 predicts inferior survival in primary gastrointestinal diffuse large B-cell lymphoma treated with CHOP-like regimen and rituximab.

Authors:  Haifeng Zhao; Le Zhang; Shanqi Guo; Tian Yuan; Bing Xia; FuLian Qu; Lianyu Zhang; Yizhuo Zhang
Journal:  Med Oncol       Date:  2014-09-07       Impact factor: 3.064

6.  Genomic imbalances and microRNA transcriptional profiles in patients with mycosis fungoides.

Authors:  Fuad Huaman Garaicoa; Alejandro Roisman; Mariana Arias; Carla Trila; Miguel Fridmanis; Alejandra Abeldaño; Silvia Vanzulli; Marina Narbaitz; Irma Slavutsky
Journal:  Tumour Biol       Date:  2016-07-29

7.  MicroRNA expression profiling and DNA methylation signature for deregulated microRNA in cutaneous T-cell lymphoma.

Authors:  Juan Sandoval; Angel Díaz-Lagares; Rocío Salgado; Octavio Servitje; Fina Climent; Pablo L Ortiz-Romero; Amparo Pérez-Ferriols; Maria P Garcia-Muret; Teresa Estrach; Mar Garcia; Lara Nonell; Manel Esteller; Ramon M Pujol; Blanca Espinet; Fernando Gallardo
Journal:  J Invest Dermatol       Date:  2014-11-18       Impact factor: 8.551

8.  Diagnostic microRNA profiling in cutaneous T-cell lymphoma (CTCL).

Authors:  Ulrik Ralfkiaer; Peter H Hagedorn; Nannie Bangsgaard; Marianne B Løvendorf; Charlotte B Ahler; Lars Svensson; Katharina L Kopp; Marie T Vennegaard; Britt Lauenborg; John R Zibert; Thorbjørn Krejsgaard; Charlotte M Bonefeld; Rolf Søkilde; Lise M Gjerdrum; Tord Labuda; Anne-Merete Mathiesen; Kirsten Grønbæk; Mariusz A Wasik; Malgorzata Sokolowska-Wojdylo; Catherine Queille-Roussel; Robert Gniadecki; Elisabeth Ralfkiaer; Carsten Geisler; Thomas Litman; Anders Woetmann; Christian Glue; Mads A Røpke; Lone Skov; Niels Odum
Journal:  Blood       Date:  2011-08-24       Impact factor: 22.113

9.  Aberrant microRNA expression in tumor mycosis fungoides.

Authors:  E Papadavid; M Braoudaki; M Bourdakou; A Lykoudi; V Nikolaou; G Tounta; A Ekonomidi; E Athanasiadis; G Spyrou; C Antoniou; S Kitsiou-Tzeli; D Rigopoulos; A Kolialexi
Journal:  Tumour Biol       Date:  2016-09-13

10.  STAT5-mediated expression of oncogenic miR-155 in cutaneous T-cell lymphoma.

Authors:  Katharina L Kopp; Ulrik Ralfkiaer; Lise Mette R Gjerdrum; Rikke Helvad; Ida H Pedersen; Thomas Litman; Lars Jønson; Peter H Hagedorn; Thorbjørn Krejsgaard; Robert Gniadecki; Charlotte M Bonefeld; Lone Skov; Carsten Geisler; Mariusz A Wasik; Elisabeth Ralfkiaer; Niels Ødum; Anders Woetmann
Journal:  Cell Cycle       Date:  2013-05-15       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.